Guizhou Xinbang Pharma Buys Hangzhou Chinese Peptide For $323 Million
Guizhou Xinbang Pharmaceutical paid $323 million to acquire Chinese Peptide Company, located in Hangzhou, from the nine companies that owned it. In addition, Xinbang raised as much as $106 million, which it will use to expand CPC's peptide production capacity. Founded in 1997, CPC describes itself as a high-quality, reasonable-cost maker of peptides and IVD reagents.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.